期刊文献+

肌苷、维生素B_6联合羚羊角颗粒治疗儿童抽动障碍的对照研究 被引量:4

A Control Study of Combination of Inosine, Vitamin B_6 and Lingyangjiao in the Treatment of Childhood Tic Disorder
下载PDF
导出
摘要 目的:比较肌苷、维生素B6联合羚羊角颗粒(简称肌苷疗法)与氟哌啶醇治疗儿童抽动障碍的疗效及安全性。方法:对愿意接受药物治疗的88例抽动障碍患儿按照随机化原则分为研究组和对照组,研究组应用肌苷疗法,对照组应用氟哌啶醇治疗,共治疗8周,在治疗前后采用耶鲁抽动症状严重程度量表(YGTSS)评定疗效,并应用副反应量表(TESS)评定氟哌啶醇不良反应,同时观察肌苷疗法有无不良反应。结果:在第8周末,研究组和对照组的治疗有效率无显著性差异(P>0.05),两组总有效率接近,研究组的不良反应显著少于对照组(P<0.05)。结论:肌苷疗法能有效治疗儿童抽动障碍,且肌苷疗法副作用少,安全性好,依从性好。 Objective:To evaluate the efficacy and side effects of the combination of Inosine,vitamin B6 and Lingyangjiao (abbr.inosine treatment) vs.haloperidol in the treatment of childhood tic disorder.Methods:A total of 88 cases of childhood tic disorder were treated with either inosine treatment (n=44) or haloperidol (n=44).The two groups were followed for 8 weeks,the efficacy of inosine treatment and haloperidol were evaluated by Yale Global Tie Severityb Scale (YGTSS).The side effects of haloperidol were evaluated by TESS.Results:The effective rates had no significant differences between the two groups in the 8th weekend (P>0.05).The side effects were significantly less in the inosine treatment group than those in the haloperidol group (P<0.05).Conclusion:Inosine treatment is as effective as haloperidol for childhood tic disorder with higher compliance.
出处 《药学与临床研究》 2013年第5期563-565,共3页 Pharmaceutical and Clinical Research
关键词 儿童 抽动障碍 肌苷疗法 氟哌啶醇 对照研究 Childhood Tic disorder Inosine treatment Haloperidol Control study
  • 相关文献

参考文献9

二级参考文献51

共引文献146

同被引文献38

  • 1姚庆和,高国栋.肌苷对帕金森病小鼠模型的神经保护作用[J].第四军医大学学报,2005,26(2):141-145. 被引量:20
  • 2陈会,钟佑泉,何志旭.儿童抽动障碍的免疫因素[J].重庆医学,2007,36(20):2107-2109. 被引量:8
  • 3John MG,Sukanta S,David C,et al.Schizophrenia:a concise overview of incidence,prevalence,and mortality[J].Epidemiol Rev,2008,30:67-76.
  • 4Xiao XL,Dawson N,Mac Intyre L,et al.Exploring metabolic pathway disruption in the subchronic phencyclidine model of schizophrenia with the Generalized Singular Value Decomposition[J].BMC Syst Bio,2011,5:72-92.
  • 5Rimol LM,Nesvag R,Hagler DJ,et al.Cortical volume,surface area,and thickness in schizophrenia and bipolar disorder[J].Biol Psychiatry,2012,71:552-560.
  • 6Silvestroff L,Bartucci S,Pasquini J,et al.Cuprizone-induced demyelination in the rat cerebral cortex and thyroid hormone effects on cortical remyelination[J].Exp Neurol,2012,235:357-367.
  • 7Chandran P,Upadhyay J,Markosyan S,et al.Magnetic resonance imaging and histological evidence for the blockade of cuprizone-induced demyelination in C57BL/6 mice[J]Neuroscience,2012,202:446-453.
  • 8Yan G,Xuan YH,Dai ZZ,et al.Brain metabolite changes in subcortical regions after exposure to cuprizone for 6 weeks:potential implications for schizophrenia[J].Neurochem Res,2015,40:49-58.
  • 9Kovacs Z,Kekesi KA,Doboly A,et al.Absence epileptic activity changing effects of non-adenosine nuckeoside inosine,guanosine,guanosine and uridine in Wistar Albino Glaxo Rijswijk rats[J].Neuroscience,2015,300:593-608.
  • 10Dutta R,Chomyk AM,Chang A,et al.Hippocampal demyelination and memory dysfunction are associated with increased levels of the neuronal micro RNA mi R-124 and reduced AMPA receptors[J].Ann Neurol,2013;73:637-645.

引证文献4

二级引证文献30

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部